Becton, Dickinson and Company (BDX) Stock Is An All Time High Flier

January 19, 2018 - By Migdalia James

Investors sentiment decreased to 0.93 in 2017 Q3. Its down 0.25, from 1.18 in 2017Q2. It fall, as 53 investors sold Becton, Dickinson and Company shares while 344 reduced holdings. 74 funds opened positions while 297 raised stakes. 197.53 million shares or 0.90% more from 195.76 million shares in 2017Q2 were reported.
Advisory Services Net Limited Liability has 13,853 shares for 0.31% of their portfolio. Engineers Gate Manager Limited Partnership holds 5,563 shares. Connecticut-based Eagle Ridge Investment has invested 0.09% in Becton, Dickinson and Company (NYSE:BDX). Palisade Asset Llc invested in 50,736 shares. Skba Mngmt Limited Liability stated it has 1,400 shares or 0.04% of all its holdings. Mackenzie Financial Corp holds 0.77% or 726,815 shares in its portfolio. Abner Herrman & Brock Limited Company holds 1,087 shares or 0.04% of its portfolio. Spf Beheer Bv has 388,447 shares. Van Hulzen Asset Mngmt Lc has invested 0.08% in Becton, Dickinson and Company (NYSE:BDX). St Germain D J Co has 53,512 shares. Gulf Bancshares (Uk) Limited accumulated 70,676 shares or 0.19% of the stock. Amundi Pioneer Asset invested 0.08% of its portfolio in Becton, Dickinson and Company (NYSE:BDX). Kayne Anderson Rudnick Inv Ltd Liability Co owns 68,067 shares. Amg Trust Bankshares has invested 0.13% in Becton, Dickinson and Company (NYSE:BDX). Whittier Trust Communications holds 0.05% or 6,654 shares in its portfolio.

Since August 9, 2017, it had 0 buys, and 9 insider sales for $15.96 million activity. Shares for $3.02M were sold by COHEN GARY M on Tuesday, August 22. The insider Strahlman Ellen R sold $1.84M. Shabshab Nabil had sold 6,149 shares worth $1.24 million. 3,500 Becton, Dickinson and Company (NYSE:BDX) shares with value of $714,210 were sold by Lim James C. 11,787 shares were sold by Sichak Stephen, worth $2.36M on Friday, September 8. Tharby Linda M also sold $941,254 worth of Becton, Dickinson and Company (NYSE:BDX) on Tuesday, August 22.

The stock of Becton, Dickinson and Company (NYSE:BDX) reached all time high today, Jan, 19 and still has $254.09 target or 9.00 % above today’s $233.11 share price. This indicates more upside for the $62.10B company. This technical setup was reported by If the $254.09 PT is reached, the company will be worth $5.59B more.
Trading stocks at an all time highs is usually a winning strategy. An all time high points to a stock which has the most positive fundamentals ever. Even thought the pullback rate is high, if correct risk management is utilized, investors can trade very well such events.

The stock increased 0.42% or $0.99 during the last trading session, reaching $233.11. About 817,105 shares traded. Becton, Dickinson and Company (NYSE:BDX) has risen 12.32% since January 19, 2017 and is uptrending. It has underperformed by 4.38% the S&P500.

Analysts await Becton, Dickinson and Company (NYSE:BDX) to report earnings on February, 1. They expect $2.43 earnings per share, up 4.29 % or $0.10 from last year’s $2.33 per share. BDX’s profit will be $647.38 million for 23.98 P/E if the $2.43 EPS becomes a reality. After $2.40 actual earnings per share reported by Becton, Dickinson and Company for the previous quarter, Wall Street now forecasts 1.25 % EPS growth.

Becton, Dickinson and Company (NYSE:BDX) Ratings Coverage

Among 19 analysts covering Becton Dickinson (NYSE:BDX), 12 have Buy rating, 0 Sell and 7 Hold. Therefore 63% are positive. Becton Dickinson had 47 analyst reports since August 7, 2015 according to SRatingsIntel. Jefferies maintained it with “Buy” rating and $23000 target in Tuesday, July 18 report. The stock of Becton, Dickinson and Company (NYSE:BDX) has “Buy” rating given on Thursday, March 30 by Jefferies. Wells Fargo initiated Becton, Dickinson and Company (NYSE:BDX) rating on Friday, September 22. Wells Fargo has “Buy” rating and $225.0 target. On Tuesday, July 18 the stock rating was maintained by Piper Jaffray with “Buy”. Citigroup initiated the shares of BDX in report on Thursday, November 12 with “Neutral” rating. The stock of Becton, Dickinson and Company (NYSE:BDX) has “Buy” rating given on Friday, June 9 by Jefferies. The stock of Becton, Dickinson and Company (NYSE:BDX) has “Hold” rating given on Friday, September 22 by RBC Capital Markets. The rating was maintained by Jefferies with “Buy” on Tuesday, September 26. The firm has “Buy” rating given on Monday, July 10 by Cowen & Co. The firm earned “Buy” rating on Thursday, February 11 by Deutsche Bank.

More important recent Becton, Dickinson and Company (NYSE:BDX) news were published by: which released: “Ex-Dividend Reminder: Becton, Dickinson, Mid-America Apartment Communities and …” on January 09, 2018, also published article titled: “FDA warns 2nd company of ‘significant violations’ in lead tests”, published: “Salem Capital Management Inc Buys AT&T Inc, Cooper Tire & Rubber Co, Becton …” on January 16, 2018. More interesting news about Becton, Dickinson and Company (NYSE:BDX) was released by: and their article: “KeyBanc Initiates Becton, Dickinson And Co. With Bullish Stance” with publication date: January 05, 2018.

Becton, Dickinson and Company develops, makes, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide. The company has market cap of $62.10 billion. It operates in two divisions, BD Medical and BD Life Sciences. It has a 50.68 P/E ratio. The BD Medical segment offers syringes, pen needles, and other products for diabetes; needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; regional anesthesia needles and trays; sharps disposal containers; closed-system transfer devices; skin antiseptic products; surgical and laparoscopic instrumentations; intravenous medication safety and infusion therapy delivery, and automated medication dispensing and supply management systems; medication inventory optimization and tracking systems; and prefillable drug delivery systems.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.